publication venue for
- First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy.. 1616-1633. 2023
- A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration. 2372-2390. 2020
- Exploration of TRPM8 Binding Sites by Carboline-based Antagonists and Their In Vitro Characterization and in Vivo Analgesic Activities. 9672-9694. 2020
- A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.. 1-12. 2019
- Identification of a Potent Tryptophan-based TRPM8 Antagonist With in vivo Analgesic Activity. . 6140-6152. 2018
- Targeting transient receptor potential vanilloid 1 channel (TRPV1) softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders. 4436-4455. 2018
- Transient Receptor Potential Melastatin 8 Channel (TRPM8) Modulation: Cool Entryway for Treating Pain and Cancer.. 10006-10029. 2016
- Tryptamine-based derivatives as Transient Receptor Potential Melastatin type-8 (TRPM8) channel modulators. 2179-2191. 2016
- Cyclometalated Iminophosphorane Gold(III) and Platinum(II). 5825-5841. 2015
- Triazine-based Vanilloid-1 Receptor Open Channel Blockers: Design, Synthesis, Evaluation and SAR analysis. 2011
- Design and synthesis of indole based peptoids as potent TRPV1 antagonists. 6133-6143. 2007
- Application of a mathematical pattern of antihistaminic activity for thr selection of new drug candidates and pharmacology assays. 3667-3673. 2006
- New Potencial Antihistaminic Compounds. Virtual Combinatorial Chemistry, Computational Screening, Real Synthesis, and Pharmacological Evaluation . 1260-1264. 2005
- Synthesis and Structure-Activity Relationships of a New Model of Arylpiperazines. 8. Computer-Assisted Design of New 5-HT1AR Agonists with Selectivity over á1-Adrenoceptors. 2548-2558. 2005